Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking.

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Abstract Text:

The availability of three-dimensional (3D) models of both drug leads (small molecule ligands) and drug targets (proteins) is essential to molecular docking and computational drug discovery. This chapter describes an emerging methodology that can be used to identify both drug leads and drug targets using three newly developed web-accessible databases: 1) DrugBank; 2) The Human Metabolome Database; and 3) PubChem. Specifically, it illustrates how putative drug targets and drug leads for exogenous diseases (i.e., infectious diseases) can be readily identified and their 3D structures selected using only the genomic sequences from pathogenic bacteria or viruses as input. It also illustrates how putative drug targets and drug leads for endogenous diseases (i.e., non-infectious diseases or chronic conditions) can be identified using similar databases and similar sequence input. This chapter is intended to illustrate how bioinformatics and cheminformatics can work synergistically to help provide the necessary inputs for computer-aided drug design.

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Methods in molecular biology (Clifton, N.J.)

VOLUME: 443

Page Numbers: 333-51

Journal Abbreviation: Methods Mol. Biol.

ISSN: 1064-3745

DAY: 30

MONTH: 04

YEAR: 2008

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9214969

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking.

AFFILIATION: Departments of Computing Science and Biological Sciences, University of Alberta, Edmonton, Canada.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Methods Mol Biol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking Related Publications

• A bayesian method for computer-aided medical diagnosis.
• A large intrathyroidal parathyroid adenoma presenting as a cold lesion on thyroid scintigraphy.
• A simple method to predict protein flexibility using secondary chemical shifts.
• Application of the random coil index to studying protein flexibility.
• BioSpider: a web server for automating metabolome annotations.
• Can the pilocarpine phenylephrine provocative test be used to detect covert angle closure?
• Cryopreservation of avian spermatozoa.
• Cumulants of multivariate multinomial distributions.
• Current Progress in computational metabolomics.
• Does the pilocarpine phenylephrine provocative test help in the management of acute and subacute angle closure glaucoma?
• Evidence for a species-specific barrier to sperm transport within the vagina of the chicken hen.
• Identifying putative drug targets and potential drug leads : starting points for virtual screening and docking.
• Improving early drug discovery through ADME modelling: an overview.
• In silico drug exploration and discovery using DrugBank.
• Introduction to cheminformatics.
• Metabolomics: a complementary tool in renal transplantation.
• Microbiological assay of mixed cephalosporins.
• Molecular mimicry of human tumor antigen by heavy chain CDR3 sequence of the anti-idiotypic antibody.
• NMR solution structures of the Apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison.
• NMR spectroscopy and protein structure determination: applications to drug discovery and development.
• P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism.
• Rapid culture test for adenovirus isolation.
• Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis.
• Rhinology in children; resume of and comments on the literature for 1948.
• Socio-cognitive understanding: a strength or weakness in Down's syndrome?
• Suicide by veterinary surgeons.
• Tetanus Toxoid and Its Use for Active Immunization.
• The initial stages of radiation damage in ionic liquids and ionic liquid-based extraction systems.
• Trabeculectomy is not the best surgical option for glaucoma.
• Understanding teachers' perceptions of the motor difficulties of children with developmental coordination disorder (DCD).